<scp>RPL35A</scp> drives ovarian cancer progression by promoting the binding of <scp>YY1</scp> to <scp>CTCF</scp> promoter
Huijuan Wu(Guangzhou University of Chinese Medicine), Qinmei Feng(Shanxi Provincial Cancer Hospital)
Cited by 5
Related Papers
AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype
|Journal of the American Society of Nephrology|2020|284
Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation
|Cell Death Discovery|2020|18